Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Stratified De-Escalated Treatment for High Risk Prostate Cancer
NCT06369610Phase 2Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Apr 2024
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in prostate cancer (PCa), sponsored by Mayo Clinic. Started Apr 2024; status: active, not recruiting.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06369610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06369610.